Evidence map›Paper›PMID 40563119›Full record

ArticleGenome biology2025

Mapping MAVE data for use in human genomics applications.

Jeremy A Arbesfeld, Estelle Y Da, James S Stevenson, Kori Kuzma, Anika Paul, Tierra Farris, Benjamin J Capodanno, Sally B Grindstaff, Kevin Riehle, Nuno Saraiva-Agostinho and 11 more

Abstract read
In one paragraph

Article in Genome biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. A scalable approach to resolving variants of uncertain significance.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Ensembl 2026.Nucleic acids research · 2026
    Article
  8. Article
  9. MaveMD: A functional data resource for genomic medicine.medRxiv : the preprint server for health sciences · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Jeremy A ArbesfeldThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
Estelle Y DaBioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Australia.
James S StevensonThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
Kori KuzmaThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
Anika PaulThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
Tierra FarrisDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Benjamin J CapodannoBrotman Baty Institute for Precision Medicine, Seattle, WA, USA.
Sally B GrindstaffBrotman Baty Institute for Precision Medicine, Seattle, WA, USA.
Kevin RiehleDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Nuno Saraiva-AgostinhoEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.
Jordan F SaferThe Center for the Development of Therapeutics, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Jonathan CasperUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.
Maximilian HaeusslerUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.
Aleksandar MilosavljevicDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Julia ForemanEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.
Helen V FirthEast Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
Sarah E HuntEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.
Sumaiya IqbalThe Center for the Development of Therapeutics, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Melissa S ClineUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.
Alan F RubinBioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Australia. alan.rubin@wehi.edu.au.
Alex H WagnerThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA. Alex.Wagner@nationwidechildrens.org.

Funding

Baylor College of Medicine/Stanford University Clinical Genome Resource (CLINGEN)U24HG009649 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI TERI Ellen KLEIN, Aleksandar Milosavljevic · 2021 to 2026
$31.5M
Technology to understand genetic variant effects in contextRM1HG010461 · NHGRI · UNIVERSITY OF WASHINGTON · PI Douglas M Fowler, Bruce Colston Trapnell · 2019 to 2026
$18.9M
The UCSC Genome BrowserU24HG002371 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Maximilian Haeussler · 2022 to 2026
$17.6M
The Future of PharmGKB Funding Under NHGRIU41HG009649 · NHGRI · STANFORD UNIVERSITY · PI MONTINE, THOMAS J, PLON, SHARON E. · 2017 to 2020
$13.4M
The Center for Actionable Variant Analysis; measuring variant function at scaleUM1HG011969 · NHGRI · UNIVERSITY OF WASHINGTON · PI Douglas M Fowler, Lea Starita · 2021 to 2026
$9.9M
Development and validation of a computable knowledge framework for genomic medicineR35HG011949 · NHGRI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI WAGNER, ALEX HANDLER · 2021 to 2025
$2.4M
Federated Analysis in Cancer Genomics: Surveying the Social, Ethical, and Regulatory LandscapeU01CA242954 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI CLINE, MELISSA SUZANNE · 2019 to 2021
$1.5M
NCI NIH HHS U01 CA242954NCI NIH HHS U01CA242954NHGRI NIH HHS HG009649NHGRI NIH HHS R35 HG011949NHGRI NIH HHS R35HG011949NHGRI NIH HHS RM1 HG010461NHGRI NIH HHS RM1HG010461NHGRI NIH HHS U24 HG002371NHGRI NIH HHS U24HG002371NHGRI NIH HHS U24 HG009649NHGRI NIH HHS U41 HG009649NHGRI NIH HHS UM1 HG011969NHGRI NIH HHS UM1HG011969NIHR Cambridge Biomedical Research Centre NIHR203312
6 · The paper itself

Abstract

backgroundExperimental data from functional assays have a critical role in interpreting the impact of genetic variants. Assay data must be unambiguously mapped to a reference genome to make it accessible, but it is often reported relative to assay-specific sequences, complicating downstream use and integration of variant data across resources. To make multiplexed assays of variant effect (MAVE) data more broadly available to the research and clinical communities, the Atlas of Variant Effects Alliance mapped MAVE data from the MaveDB community database to human reference sequences, creating an extensive set of machine-readable homology mappings that are incorporated into widely used human genomics applications.

resultsHere, we map approximately 9.0 million individual protein and nucleotide variants in MaveDB to the human genome, describing the examined variants with respect to human reference sequences while preserving the data provenance of the original MAVE sequences. We then disseminate the results to major genomic resources including the Genomics 2 Proteins Portal, UCSC Genome Browser, Ensembl Variant Effect Predictor, and DECIPHER platform. Within these applications, MAVE variants can now be visualized and integrated with other relevant clinical and biological data, making additional knowledge available when performing variant interpretation and conducting other research activities.

conclusionsMapping MAVE variants to human reference sequences and sharing the mapped dataset with several key human genomics applications enables a new and diverse set of applications for MAVE data. This study provides increased access to functional data that can assist in clinical variant interpretation pipelines and enable biomedical research and discovery.

Indexed as

Chromosome MappingGenetic VariationGenome, HumanGenomicsDatabases, GeneticHumansDeep mutational scanningFunctional assayGenomic medicineGenomicsGlobal Alliance for Genomics and HealthMassively parallel reporter assaysMultiplexed assays of variant effectVariation representation specification

Identifiers

PMID40563119
PMCPMC12188674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.